| Style | Citing Format |
|---|---|
| MLA | Rabani F, et al.. "Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma." Clinical Nuclear Medicine, vol. , no. , 2026, pp. -. |
| APA | Rabani F, Elahifard H, Tanha A S, Bari A, Askari E (2026). Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma. Clinical Nuclear Medicine, (), -. |
| Chicago | Rabani F, Elahifard H, Tanha A S, Bari A, Askari E. "Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma." Clinical Nuclear Medicine , no. (2026): -. |
| Harvard | Rabani F et al. (2026) 'Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma', Clinical Nuclear Medicine, (), pp. -. |
| Vancouver | Rabani F, Elahifard H, Tanha A S, Bari A, Askari E. Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma. Clinical Nuclear Medicine. 2026;():-. |
| BibTex | @article{ author = {Rabani F and Elahifard H and Tanha A S and Bari A and Askari E}, title = {Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma}, journal = {Clinical Nuclear Medicine}, volume = {}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Rabani F AU - Elahifard H AU - Tanha A S AU - Bari A AU - Askari E TI - Diagnostic Superiority of 68Ga-Fapi Pet/Ct Over 18F-Fdg in Restaging of Advanced Epithelioid Sarcoma JO - Clinical Nuclear Medicine VL - IS - SP - EP - PY - 2026 ER - |